Trials / Unknown
UnknownNCT05197686
Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.
Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia: Prognosis and Impact on the Respiratory and Cardiovascular Systems.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Pomeranian Medical University Szczecin · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to compare two methods of oxygen therapy in patients with acute respiratory distress syndrome in the course of SARS-CoV2 pneumonia. The initial method of oxygen supply during coronavirus pneumonia is conventional oxygen therapy using a face mask or nasal cannula. However, there have been reports in the literature that early initiation of high-flow oxygen therapy with a nasal cannula is associated with better prognosis. The study we perform is intended to provide reliable evidence for confirmation this hypothesis.
Conditions
- Corona Virus Infection
- ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
- Oxygen Deficiency
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Oxygen theraphy with high flow nasal cannule | Oxygen theraphy with high flow nasal cannule |
| DEVICE | Oxygen theraphy with mask with reservoir | Oxygen theraphy with mask with reservoir |
Timeline
- Start date
- 2022-01-18
- Primary completion
- 2022-06-30
- Completion
- 2022-12-31
- First posted
- 2022-01-19
- Last updated
- 2022-01-19
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT05197686. Inclusion in this directory is not an endorsement.